Kohlberg Kravis Roberts
KKR
$96.90
-0.11%
KKR & Co. Inc. is one of the world's largest alternative asset managers, operating across private equity, credit, infrastructure, real estate, and public markets, and has expanded into insurance through its acquisition of Global Atlantic Financial Group. The firm is a dominant market leader in private markets, distinguished by its scale with over $723 billion in managed assets and a strategic platform that combines capital allocation with permanent insurance capital. The current investor narrative is intensely focused on the firm's aggressive deployment into high-growth areas like AI infrastructure, as evidenced by its $10 billion Helix Digital Infrastructure launch, while simultaneously navigating market concerns over private credit stress and the performance of its strategic holdings in a volatile macro environment.…
KKR
Kohlberg Kravis Roberts
$96.90
Related headlines
Investment Opinion: Should I buy KKR Today?
Rating & Thesis: KKR is a HOLD for risk-tolerant investors, as the compelling forward valuation is currently overshadowed by severe technical damage and sector headwinds. The core thesis is that the stock offers attractive value if the projected earnings recovery materializes (forward P/E 13.12x), but investors should wait for evidence of a technical bottom and abating credit fears before establishing a full position, aligning with the mixed but cautious analyst sentiment.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The significant discount implied by the forward P/E of 13.12x versus the trailing 47.88x, 2) Robust Q4 revenue growth of 72.5% YoY and strong TTM FCF of $7.52B demonstrating underlying earning power, 3) A clear strategic growth catalyst in the $10B Helix Digital Infrastructure launch, and 4) The stock's deep undervaluation relative to its 52-week high of $153.87, offering long-term upside if sentiment recovers. However, these positives are counterbalanced by the severe -45.75% one-year relative strength and high beta of 1.79.
Risks & Conditions: The two biggest risks are a failure to achieve the forward EPS of $9.50, and a worsening of the private credit stress that continues to drive sector-wide selling. This Hold would upgrade to a Buy if the stock establishes sustained support above $105, signaling a break in the downtrend, or if Q1 2026 earnings strongly reaffirm the path to the $9.50 EPS target. It would downgrade to a Sell on a confirmed break below the $82.67 support level. Relative to its own history and the current macro backdrop, the stock is fairly valued to slightly undervalued on forward earnings, but overvalued on a trailing basis, indicating a market in transition between punishing past volatility and pricing in future growth.
Sign up to view all
KKR 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The valuation argument is compelling on a forward basis, and the firm's scale and strategic moves are strong. However, the technical picture is severely broken, and sector headwinds are real. The high probability base case sees a grinding recovery as earnings materialize, but the high beta and sentiment risk warrant caution. The stance would upgrade to bullish on a confirmed technical reversal above $105 coupled with stable quarterly earnings. It would turn bearish on a break below $82.67, which would signal a failure of the current support and likely lead to a re-test of lower prices.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kohlberg Kravis Roberts's 12-month outlook, with a consensus price target around $125.97 and implied upside of +30.0% versus the current price.
Average Target
$125.97
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$78 - $126
Analyst target range
Analyst coverage for KKR appears limited, with only two analysts providing estimates in the dataset, suggesting institutional coverage may be more extensive but the provided data point indicates a potential gap. The consensus sentiment, based on recent institutional ratings, is bullish, with firms like Barclays (Overweight), UBS (Buy), and BMO Capital (Outperform) maintaining positive stances, though TD Cowen downgraded to Hold in January 2026, indicating some caution. The average revenue estimate for the forward period is $9.74 billion, with a wide range from $9.10 billion to $10.38 billion, and the average EPS estimate is $9.50, ranging from $8.69 to $10.31; this wide target spread signals high uncertainty around the timing and magnitude of the company's investment realization cycles and the impact of its new growth ventures like Helix Digital Infrastructure.
Bulls vs Bears: KKR Investment Factors
The investment debate for KKR centers on a stark tension between its compelling forward fundamentals and its deeply damaged technical and sentiment picture. The bull case is anchored in a projected earnings surge (forward P/E of 13.12x), strategic growth in AI infrastructure, and robust cash generation. The bear case is dominated by severe price underperformance, high volatility, and sector-wide fears over private credit. Currently, the bearish evidence from price action and sentiment appears stronger in the near term, as the stock's 45%+ underperformance versus the market cannot be ignored. The single most important factor that will resolve the thesis is whether the company can deliver on the analyst-expected $9.50 EPS in the coming year, thereby validating its forward valuation and overcoming the pervasive negative sentiment gripping the alternative asset manager sector.
Bullish
- Strong Forward Earnings Growth: Analysts project a forward EPS of $9.50, a massive increase from the recent quarterly EPS of $1.24, implying a forward P/E of only 13.12x. This suggests the market is pricing in a significant earnings recovery, driven by strategic initiatives and investment realizations.
- Robust Q4 Revenue & Cash Flow: Q4 2025 revenue surged 72.5% YoY to $5.52 billion, demonstrating the firm's ability to generate substantial investment income. This is supported by strong trailing twelve-month free cash flow of $7.52 billion, providing ample capital for growth and shareholder returns.
- Strategic Growth in AI Infrastructure: The recent launch of the $10 billion Helix Digital Infrastructure fund positions KKR to capitalize on high-growth AI-related investments. This strategic pivot into a secular growth trend provides a powerful long-term catalyst beyond traditional private equity cycles.
- Dominant Scale & Market Position: With over $723 billion in managed assets, KKR is a global leader in alternative asset management. This scale provides significant competitive advantages in deal sourcing, fundraising, and operational synergies, particularly with its integrated insurance platform.
Bearish
- Severe Technical Downtrend & Underperformance: The stock is down 20.76% over the past year and 25.73% over six months, drastically underperforming the S&P 500 by -45.75%. Trading at 63% of its 52-week range ($82.67-$153.87) indicates persistent selling pressure and broken investor confidence.
- Extremely High Volatility & Leverage: A beta of 1.79 means KKR's stock is 79% more volatile than the market, amplifying downside risk. This is compounded by a debt-to-equity ratio of 1.77, typical for the model but increasing financial risk in a rising rate or stressed credit environment.
- Lumpy, Inconsistent Profitability: Operating margin swung from 40.0% in Q4 2025 to 9.4% in Q3 2025, while gross margin compressed from 35.6% to 24.7%. This volatility underscores the cyclical, transaction-driven nature of earnings, making reliable forecasting difficult.
- Elevated Trailing Valuation: The trailing P/E of 47.88x is historically high for KKR and leaves little room for error. This elevated multiple, coupled with a Price/Sales ratio of 5.89x, suggests the stock is priced for perfection on future earnings growth that may not materialize smoothly.
KKR Technical Analysis
The stock is in a pronounced downtrend, having declined 20.76% over the past year and 25.73% over the last six months, significantly underperforming the S&P 500's 24.99% gain. Currently trading at $97.01, the price sits at approximately 63% of its 52-week range ($82.67 to $153.87), indicating it is closer to its lows than its highs, which suggests a potential value opportunity but also reflects persistent selling pressure and negative sentiment. Recent momentum shows a modest short-term recovery, with the stock up 4.40% over the past month and 7.79% over three months, diverging positively from the longer-term downtrend; however, this nascent rebound remains fragile, occurring against a backdrop of extreme market-relative weakness, as evidenced by a -45.75% one-year relative strength versus the S&P 500. Key technical support is clearly defined at the 52-week low of $82.67, while major resistance looms at the 52-week high of $153.87; a sustained break below support would signal a continuation of the bear trend, whereas reclaiming levels above $105 is needed to suggest a more durable recovery. The stock's high beta of 1.79 indicates it is approximately 79% more volatile than the broader market, which amplifies both downside risk and potential upside but necessitates careful risk management for investors.
Beta
1.79
1.79x market volatility
Max Drawdown
-44.9%
Largest decline past year
52-Week Range
$83-$154
Price range past year
Annual Return
-21.0%
Cumulative gain past year
| Period | KKR Return | S&P 500 |
|---|---|---|
| 1m | +3.0% | -0.2% |
| 3m | +6.6% | +14.0% |
| 6m | -25.9% | +7.8% |
| 1y | -21.0% | +25.3% |
| ytd | -24.8% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KKR Fundamental Analysis
Revenue growth has been volatile but showed a significant surge in the most recent quarter, with Q4 2025 revenue of $5.52 billion representing a robust 72.5% year-over-year increase; however, this follows a choppy multi-quarter pattern where revenue dipped to $3.05 billion in Q1 2025 before recovering, indicating performance is heavily influenced by lumpy realized investment income rather than stable fee streams. The company is profitable, posting net income of $1.15 billion in Q4 2025, but profitability metrics are inconsistent, with gross margin compressing from 35.6% in Q4 2025 to 24.7% in Q3 2025, and operating margin swinging dramatically from 40.0% to 9.4% over the same period, reflecting the cyclical and transaction-driven nature of its earnings. The balance sheet is leveraged with a debt-to-equity ratio of 1.77, which is typical for an asset manager utilizing balance sheet capital, but financial health is supported by substantial liquidity, evidenced by a current ratio of 79.85 and strong cash generation, with trailing twelve-month free cash flow of $7.52 billion providing ample internal funding for growth and shareholder returns.
Quarterly Revenue
$5.5B
2025-12
Revenue YoY Growth
+0.72%
YoY Comparison
Gross Margin
+0.35%
Latest Quarter
Free Cash Flow
$7.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KKR Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 47.88x, while the forward P/E is significantly lower at 13.12x, indicating the market expects a substantial earnings recovery in the coming year, as analyst EPS estimates average $9.50 versus the most recent quarterly EPS of $1.24. Compared to sector averages, KKR's trailing P/E of 47.88x and Price/Sales ratio of 5.89x are not directly comparable to a standard industry average from the provided data, but the forward P/E of 13.12x suggests the market is pricing in normalized, growth-adjusted earnings, with any premium likely tied to its leading market position and insurance platform synergy. Historically, the stock's current trailing P/E of 47.88x is near the upper end of its own range over the past several years, which has seen ratios fluctuate from negative figures during loss-making quarters to highs above 100x; this elevated level suggests the market is currently pricing in optimistic expectations for earnings normalization and growth from recent strategic initiatives, leaving little margin for disappointment.
PE
50.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -138x~1160x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
23.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: KKR's primary financial risk stems from the inherent lumpiness and cyclicality of its earnings, as evidenced by operating margin swings from 40.0% to 9.4% between recent quarters. This makes the stock highly sensitive to the timing of investment realizations. While the balance sheet carries moderate leverage (Debt/Equity of 1.77), the greater risk is revenue concentration in volatile performance fees and carried interest, which can lead to significant earnings misses if exit markets deteriorate. The firm's aggressive growth bets, like the $10B Helix fund, also introduce execution risk and capital commitment during a period of market uncertainty.
Market & Competitive Risks: The stock faces acute valuation compression risk, trading at a trailing P/E of 47.88x amidst a severe downtrend; any disappointment in the anticipated earnings recovery could trigger further multiple contraction. Externally, the entire sector is grappling with fears over private credit stress and potential defaults, as highlighted by recent news of peer fund redemption caps. KKR's high beta of 1.79 means it is disproportionately exposed to broader market sell-offs and risk-off sentiment. Furthermore, intense competition for assets from peers like Apollo and Blackstone could pressure future fee margins and investment returns.
Worst-Case Scenario: The most damaging scenario involves a confluence of a deepening private credit crisis, a prolonged freeze in the IPO and M&A markets hindering realizations, and a broader equity bear market. This would crush performance fees, trigger write-downs in the portfolio, and lead to significant earnings misses versus the $9.50 EPS estimate. In this adverse environment, the stock could re-test and break below its 52-week low of $82.67, representing a downside of approximately -15% from the current ~$97 level. A more severe drawdown towards the stock's recent max drawdown of -44.87% is possible if systemic fears escalate, implying a potential loss of 30-40% from current levels.
FAQ
The key risks are, in order of severity: 1) Market & Sentiment Risk: The stock has a high beta of 1.79 and is in a severe downtrend, making it vulnerable to further broad market declines and sustained negative sentiment. 2) Execution Risk: The company must deliver on the anticipated earnings recovery to a $9.50 EPS; any delay or shortfall could crash the forward valuation thesis. 3) Credit & Macro Risk: Fears of stress in private credit portfolios, a core business line, could lead to write-downs and reduced fee income. 4) Financial Risk: Operating and gross margins are highly volatile quarter-to-quarter, and the firm employs leverage (D/E 1.77) typical for its model.
Based on a probabilistic framework, the 12-month forecast for KKR includes three scenarios. The Base Case (50% probability) sees the stock trading between $105 and $130 as earnings gradually recover toward the $9.50 target. The Bull Case (30% probability), driven by successful AI fund deployment and strong realizations, targets $135 to $155. The Bear Case (20% probability), triggered by credit losses and earnings misses, could see the stock fall to between $75 and $90. The most likely outcome is the base case, contingent on KKR providing consistent quarterly evidence that its earnings are on the projected path.
KKR's valuation presents a paradox: it appears significantly overvalued on a trailing basis with a P/E of 47.88x, but potentially undervalued on a forward basis with a P/E of 13.12x. This discrepancy highlights the market's expectation of a massive earnings rebound. Compared to its own 52-week high of $153.87, the current price near $97 seems undervalued. Ultimately, the stock is fairly valued to slightly undervalued if the projected $9.50 EPS is achieved, but it carries a high premium of investor faith that this growth will materialize without hiccups.
KKR presents a high-risk, high-potential-reward opportunity that is not suitable for all investors. For a risk-tolerant investor with a multi-year horizon, the forward P/E of 13.12x and analyst target EPS of $9.50 suggest significant upside if the company executes. However, it is not a 'good buy' for conservative investors, given its 1-year underperformance of -45.75% vs. the market, high beta of 1.79, and ongoing sector fears. A prudent approach would be to consider a starter position on further weakness, with plans to average in if the technical picture improves and earnings confirm the recovery narrative.
KKR is unequivocally a long-term investment, requiring a minimum holding period of 2-3 years to allow its earnings cycle to play out and for sector sentiment to potentially recover. Its high beta (1.79) and volatile, lumpy earnings make it a poor candidate for short-term trading, as price swings can be severe and unpredictable. The investment thesis is based on the realization of forward earnings estimates and strategic initiatives like the Helix fund, which are multi-year projects. There is no meaningful dividend to support a short-term hold (yield 0.68%). Therefore, only investors with a long-term horizon and high risk tolerance should consider KKR.